BI
TAK icon

Binnacle Investments’s Takeda Pharmaceutical TAK Stock Holding History

Binnacle Investments’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$7.61K Buy
520
+244
+88% +$3.62K ﹤0.01% 466
2025
Q2 		$4.27K Buy
+276
New +$4.08K ﹤0.01% 478

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Binnacle Investments's TAK Position: Q3 2025 in Review

Binnacle Investments increased its Takeda Pharmaceutical (TAK) stake by 88% in Q3 2025, buying an estimated $3.62K and bringing the position to 520 shares worth $7.61K. The position accounts for ﹤0.01% of the portfolio, ranked #466.

Binnacle Investments first reported a position in TAK in Q2 2025 and has held it in 2 quarters since. 329 funds tracked by Wall St. Rank hold TAK as of Q3 2025.

  • Binnacle Investments held 520 shares of Takeda Pharmaceutical worth $7.61K as of Q3 2025.
  • Binnacle Investments bought 244 Takeda Pharmaceutical shares in Q3 2025, an estimated $3.62K.
  • Takeda Pharmaceutical made up ﹤0.01% of Binnacle Investments's portfolio in Q3 2025, its #466 holding.
  • Binnacle Investments first reported a position in Takeda Pharmaceutical in Q2 2025 and has held it in 2 quarters since.
  • 329 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2025.

Based on Binnacle Investments's 13F filing for Q3 2025, filed 14 Nov 2025.